NCT01802814 2024-02-09International Study for Treatment of Standard Risk Childhood Relapsed ALL 2010Charite University, Berlin, GermanyPhase 3 Completed700 enrolled
NCT00941928 2014-05-22Haploidentical Natural Killer (NK) Cells With Epratuzumab for Relapsed Acute Lymphoblastic Leukemia (ALL)M.D. Anderson Cancer CenterPhase 2 Terminated2 enrolled 3 charts